Check out the on-demand sessions from the Low-Code/No-Code Summit to learn how to successfully innovate and achieve efficiency by upskilling and scaling citizen developers. Watch now.
Counsyl, maker of DNA tests used to diagnose predispositions to genetic diseases in prospective parents before they conceive, has brought in $2.2 million in equity, according to a filing with the SEC. Based in Redwood City, Calif., the company raised $2.7 million in 2009 from 21 undisclosed investors. The company got a write-up in The New York Times at the end of January.
VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Discover our Briefings.